APA

Holland M. C., Wurthner J. U., Morley P. J., Birchler M. A., Lambert J., Albayaty M., Serone A. P., Wilson R., Chen Y., Forrest R. M., Cordy J. C., Lipson D. A. & Bayliffe A. I. (20140423). Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1. : Journal of clinical immunology.

Chicago

Holland M C, Wurthner J U, Morley P J, Birchler M A, Lambert J, Albayaty M, Serone A P, Wilson R, Chen Y, Forrest R M, Cordy J C, Lipson D A and Bayliffe A I. 20140423. Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1. : Journal of clinical immunology.

Harvard

Holland M. C., Wurthner J. U., Morley P. J., Birchler M. A., Lambert J., Albayaty M., Serone A. P., Wilson R., Chen Y., Forrest R. M., Cordy J. C., Lipson D. A. and Bayliffe A. I. (20140423). Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1. : Journal of clinical immunology.

MLA

Holland M C, Wurthner J U, Morley P J, Birchler M A, Lambert J, Albayaty M, Serone A P, Wilson R, Chen Y, Forrest R M, Cordy J C, Lipson D A and Bayliffe A I. Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1. : Journal of clinical immunology. 20140423.